U.S. Physical Therapy (NYSE:USPH) Posts Earnings Results, Misses Estimates By $0.07 EPS

U.S. Physical Therapy (NYSE:USPH) released its earnings results on Thursday. The company reported $0.30 EPS for the quarter, missing the Zacks’ consensus estimate of $0.37 by ($0.07), MarketWatch Earnings reports. The firm had revenue of $112.70 million during the quarter, compared to analysts’ expectations of $101.89 million. U.S. Physical Therapy had a net margin of 6.17% and a return on equity of 13.48%. The company’s revenue for the quarter was down 3.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.66 EPS.

USPH stock opened at $75.75 on Friday. U.S. Physical Therapy has a twelve month low of $45.13 and a twelve month high of $148.48. The company has a quick ratio of 1.41, a current ratio of 2.09 and a debt-to-equity ratio of 0.75. The firm has a market cap of $972.94 million, a PE ratio of 30.79, a price-to-earnings-growth ratio of 13.87 and a beta of 1.28. The business has a 50 day moving average of $68.70 and a 200 day moving average of $100.77.

A number of research analysts have recently commented on the company. ValuEngine upgraded U.S. Physical Therapy from a “hold” rating to a “buy” rating in a research note on Thursday, April 30th. Sidoti cut U.S. Physical Therapy from a “buy” rating to a “neutral” rating in a research note on Thursday, April 30th. Barrington Research lowered their target price on U.S. Physical Therapy from $130.00 to $120.00 and set an “outperform” rating for the company in a research note on Friday, February 28th. William Blair cut U.S. Physical Therapy from an “outperform” rating to a “hold” rating in a research note on Tuesday, March 17th. Finally, Zacks Investment Research upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Thursday. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $115.00.

In related news, Director Regg E. Swanson acquired 1,000 shares of U.S. Physical Therapy stock in a transaction that occurred on Friday, March 13th. The stock was bought at an average price of $85.68 per share, with a total value of $85,680.00. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link. In the last ninety days, insiders have purchased 4,000 shares of company stock valued at $338,960. 2.50% of the stock is owned by corporate insiders.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Article: Why do commodities matter?

Earnings History for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.